BioMarin Pharmaceutical Inc. (B1MR34)
Market Closed
10 Aug, 19:55
B3 B3 Primary R$
170. 37
+9.27
+5.7542%
R$
54.45B Market Cap
126.18 P/E Ratio
- Div Yield
1 Volume
1 Eps
R$ 161.1
Previous Close Want to track B1MR34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BioMarin Pharmaceutical Inc. (B1MR34) Statistics
Valuation metrics
Market Cap 54.45B
Enterprise value 118.42B
Trailing P/E (ttm) 39
Forward P/E -
PEG ratio -0.9
Price/Sales (ttm) 16.18
Price/Book (mrq) 0.84
Enterprise Value/Revenue 7.28
Enterprise Value/EBITDA 37.41
Overview
Shares outstanding 193.27M
Float 192.17M
Shares short -
% Held by insiders -
% Held by institutions 0%
Average volume (10 days) 201
Average volume (90 days) 88
Price summary
52-Week low 123.51
52-Week high 171.95
Beta 0.23
50-Day moving average 142.98
200-Day moving average 149.28
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.08%
Operating margin 0.18%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.04%
Income Statement
Revenue (ttm) 16.26B
Revenue per share (ttm) 16.87
Quarterly revenue growth (yoy) 0.03%
Gross profit (ttm) 8.32B
EBITDA 572.94M
Net income to common (ttm) 1.35B
Diluted EPS (ttm) 3.48
Quarterly earnings growth (yoy) -0.43%
Balance Sheet
Total cash (mrq) 11.14B
Total cash per share (mrq) 11.5
Total debt (mrq) 7.22B
Total Debt/Equity (mrq) 23.17
Current ratio (mrq) 5.81%
Book value per share (mrq) 161.18
Cash Flow
Cash flow statement 4.38B
Levered free cash flow (LFCF) 2.3B
